Early Life and Background
Marc Rubiralta is a Spanish billionaire. His father, José María Rubiralta, founded Werfen in 1966 as a distributor of medical supplies. Werfen evolved into a global leader in in-vitro diagnostics.
Rise to Success
Marc Rubiralta, along with his brothers, owns and runs Werfen. He became the chairman of Werfen in 2019. One of his significant strategic moves was the $2 billion acquisition of U.S.-based Immucor. His leadership has contributed to the company's position in the diagnostics market. He also co-owns the Celsa Group, one of Spain's largest industrial groups.
Key Business Strategies
Werfen's growth strategy involved acquiring companies such as Tem and Accriva Diagnostics. Werfen's success is rooted in its ability to produce high-quality diagnostics. Marc Rubiralta has also been involved in expanding the company commercially in the United States and China.
Philanthropy
Information about Marc Rubiralta's specific philanthropic activities could not be found.